These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 126694)

  • 21. Dehydroepiandrosterone sulphate loading test and determination of plasma oestetrol concentration in late pregnancy.
    Schollberg K; Seiler E; Wagner S
    Exp Clin Endocrinol; 1985 Apr; 85(2):204-8. PubMed ID: 3160598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oestrone, oestradiol-17beta and oestriol levels in human foetal plasma during gestation and at term.
    Shutt DA; Smith ID; Shearman RP
    J Endocrinol; 1974 Feb; 60(2):333-41. PubMed ID: 4815987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Estrogen: estrone (E1), estradiol (E2), estriol (E3) and estetrol (E4)].
    Shimizu Y
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():425-38. PubMed ID: 16149545
    [No Abstract]   [Full Text] [Related]  

  • 24. Diagnosis of intrauterine fetal growth retardation (IUGR) and placental insufficiency by a dehydroepiandrosterone sulfate (DHAS) loading test.
    Rabe T; Hösch R; Runnebaum B
    Biol Res Pregnancy Perinatol; 1983; 4(3):130-6. PubMed ID: 6226324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Half-life of dehydroepiandrosterone sulfate (DHAS) during pregnancy].
    Cohen H; Cohen MM
    C R Acad Hebd Seances Acad Sci D; 1976 Jun; 282(22):1875-8. PubMed ID: 133767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma estradiol-17 beta as an index of fetoplacental function.
    Chew PC; Ratnam SS
    Int J Gynaecol Obstet; 1976; 14(5):445-8. PubMed ID: 15913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of dehydroepiandrosterone sulfate on uterine cervical ripening in late pregnancy.
    Mochizuki M; Maruo T
    Acta Physiol Hung; 1985; 65(3):267-74. PubMed ID: 2990160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Further investigation on the predictive value of human placental lactogen in high-risk pregnancies.
    Granat M; Sharf M; Diengott D; Spindel A; Kahana L; Elrad H
    Am J Obstet Gynecol; 1977 Nov; 129(6):647-54. PubMed ID: 920766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors influencing urinary estrogen excretion in pregnancy.
    Talbert LM; Easterling WE
    Am J Obstet Gynecol; 1967 Dec; 99(7):923-32. PubMed ID: 4228654
    [No Abstract]   [Full Text] [Related]  

  • 30. A radioimmunoassay for total (unconjugated + conjugated) oestrone in plasma from pregnant women; the response of total oestrone in plasma to an intravenous injection of dehydroepiandrosterone sulphate (DHAS).
    Axelsson O; Nilsson BA; Johansson ED
    J Steroid Biochem; 1978 Nov; 9(11):1119-23. PubMed ID: 218057
    [No Abstract]   [Full Text] [Related]  

  • 31. Fetoplacental steroid metabolism in prolonged pregnancies.
    Reynolds JW; Burry K; Carlson CV
    Am J Obstet Gynecol; 1986 Jan; 154(1):74-9. PubMed ID: 2936245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on oestriol synthesis from dehydroepiandrosterone sulphate in human pregnancy.
    Kirschner MA; Wiqvist N; Diczfalusy E
    Acta Endocrinol (Copenh); 1966 Dec; 53(4):584-97. PubMed ID: 4224609
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of smoking on fetoplacental-maternal system during pregnancy.
    Mochizuki M; Maruo T; Masuko K; Ohtsu T
    Am J Obstet Gynecol; 1984 Jun; 149(4):413-20. PubMed ID: 6203408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary estriol excretion before severe placental abruption.
    Beischer NA; Brown JB; Macafee J
    Obstet Gynecol; 1970 Nov; 36(5):697-701. PubMed ID: 5473999
    [No Abstract]   [Full Text] [Related]  

  • 35. A new method for evaluation of urinary estriol determinations.
    Nelson GH
    Am J Obstet Gynecol; 1970 Mar; 106(5):649-55. PubMed ID: 4244287
    [No Abstract]   [Full Text] [Related]  

  • 36. A rapid, combined chromatographic method for urinary estriol in pregnancy.
    Dito WR; Shelly J
    Am J Clin Pathol; 1969 Feb; 51(2):177-84. PubMed ID: 5766473
    [No Abstract]   [Full Text] [Related]  

  • 37. Neutral C19-steroids and steroid sulfates in human pregnancy. 3. Dehydroepiandrosterone sulfate, 16-alpha-hydroxydehydroepiandrosterone, and 16-alpha-hydrosydehydroepiandrosterone sulfate in cord blood and blood of pregnant women with and without treatment with corticoids.
    Simmer HH; Dignam WJ; Easterling WE; Frankland MV; Naftolin F
    Steroids; 1966 Aug; 8(2):179-93. PubMed ID: 4227249
    [No Abstract]   [Full Text] [Related]  

  • 38. Proteinuria and outcome of 444 pregnancies complicated by hypertension.
    Ferrazzani S; Caruso A; De Carolis S; Martino IV; Mancuso S
    Am J Obstet Gynecol; 1990 Feb; 162(2):366-71. PubMed ID: 2309816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Plasma concentration of estrone, estradiol and estriol after dehydroepiandrosterone-sulphate load test in normal and abnormal pregnancy--new discoveries about the kinetics of the DHEA-S test (author's transl)].
    Künzig HJ; Geiger W; Gwuzdz P
    Z Geburtshilfe Perinatol; 1974 Aug; 178(4):245-53. PubMed ID: 4280662
    [No Abstract]   [Full Text] [Related]  

  • 40. The dehydroepiandrosterone loading test. IV. Evaluation of clinical utility.
    Nagey DA; Pupkin MJ; Mandeville L; Schomberg DW; Crenshaw C
    Am J Obstet Gynecol; 1982 Jan; 142(1):60-5. PubMed ID: 6459738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.